Answers are grounded in this paper and cite their sources.
This study was undertaken to analyze whether the rate of breakthrough seizures in patients taking antiseizure medication (ASM) who have been seizure-free for at least 12 months varies among different types and etiologies of epilepsy. Given the relative ease of achieving seizure freedom with ASM in patients with post-ischemic stroke epilepsy, we hypothesized that this etiology is associated with a reduced risk of breakthrough seizures.
No takes yet. Share an insight, caveat, or question.
Doerrfuss et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: